tbuckley/cabot-search huggingface dataset:
Patients' competence in oral cancer therapies.
Authors: Christoph Riese, Anja Beylich, Manfred Welslau, Jasmin Benser, Uirassu Borges, Walter Baumann
Journal: Journal of Clinical Oncology (2015)

TPS6624 Background: Oral agents for cancer treatment are increasingly prescribed. Regardless the benefits of oral agents, oral cancer medications have a considerable potential for side-effects, toxicity and drug interactions. Inadequate use of medication therefore leads to ineffectiveness of medication and in some cases to early breakup of therapy. This type of therapy requires a high level of self-management competence of the patient and her/his social setting. A standardized recurring patient education program by oncology nurses may influence the handling of the oral agents in a positive way. We evaluated whether providing adequate information on the clinical picture, treatment options, side effects, and the proper handling of medication influences therapy adherence, self-management ability, and eventually therapeutic success. Methods: The cluster randomized controlled study was conducted from March until December 2014. This trial took part in total 28 office based oncology practices all over Germany. The oncology nurses for the intervention group were specially trained for the education program in techniques of motivational communication and the usage of oral agents. The intervention (n = 17 practices) was conducted in addition to the counselling for therapy, by the oncologist. The control group received only the oncologists counseling. Primary endpoint was the patient's competence measured by a combination of the tools: self-efficacy, quality of life and therapy related knowledge. Secondary endpoints are side-effects, health related stress, overall dose and break up rate. The analysis of the data is still ongoing and will be finished in April 2015. Clinical trial information: VfD_PACOCT_12_003487.
Pediatrics, Springfield, Illinois
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Many address task of preventing research fraud
Authors: B. Merz
Journal: JAMA (1988)

ON SEPT 19, Stephen J. Breuning, PhD, entered a plea of guilty in US District Court in Baltimore to two counts of falsifying information to the National Institute of Mental Health (NIMH). The same day the<i>Federal Register</i>published proposed regulations designed to keep situations like Breuning's from happening again. Breuning admitted that he had falsified data in reports to the NIMH while director of the John Merck Program at the University of Pittsburgh's Western Psychiatric Institute. The studies, in which the effects of neuroleptic drugs were compared with those of stimulants in controlling behavior disorders in mentally retarded children, had been conducted earlier at Coldwater Regional Center for Developmental Disabilities in Michigan. According to one of the prosecutors in the case, Assistant US Attorney E. Thomas Roberts, Breuning reported results from 99 patients when data had been taken from only 25. Although the government dropped a charge of obstructing
Palliative irradiation for liver metastases
Authors: M. Turek-Maischeider
Journal: JAMA (1975)

Eleven patients underwent palliative irradiation for symptomatic liver metastases. The whole liver is included in the radiation field. The treatment is given with a cobalt teletherapy unit. Daily doses are 150 rads calculated in the midliver plane. The total dose employed is 2,500 rads given in a three-week period. Eight patients had good response, two moderate response, and one patient failed to respond to treatment. Liver function studies and liver scans also reflected the treatment response. All patients tolerated the treatment and no deaths were attributed to liver irradiation. The impression is that radiation therapy is valuable for the treatment of symptomatic liver metastases in the young patient who does not have a terminal condition. (<i>JAMA</i>232:625-628, 1975)
Error in Byline
Journal: JAMA Oncology (2015)

Samantha Hansford, MSc; Pardeep Kaurah, MSc; Hector Li-Chang, MD; Michelle Woo, PhD; Janine Senz, BSc; Hugo Pinheiro, PhD; Kasmintan A. Schrader, MBBS, PhD; David F. Schaeffer, MD; Karey Shumansky, MSc; George Zogopoulos, MD; Teresa Almeida Santos, MD, PhD; Isabel Claro, MD; Joana Carvalho, PhD; Cydney Nielsen, PhD; Sarah Padilla, BSc; Amy Lum, BSc; Aline Talhouk, PhD; Katie Baker-Lange, MSc; Sue Richardson, RGN; Ivy Lewis, BN, RN; Noralane M. Lindor, MD; Erin Pennell, RN; Andree MacMillan, MSc; Bridget Fernandez, MD; Gisella Keller, PhD; Henry Lynch, MD; Sohrab P. Shah, PhD; Parry Guilford, MSc, PhD; Steven Gallinger, MD; Giovanni Corso, MD, PhD; Franco Roviello, MD; Carlos Caldas, MD; Carla Oliveira, PhD; Paul D. P. Pharoah, PhD; David G. Huntsman, MD
Infectious disease
Authors: E. S. Tatty, A. G. Soemantri, S. T. Moelyono, B. Persadaan, Baruch Yerushalmi, Eliezer Shahak, Tamar Berenstein, Shaul Sofer, J. F. Riera-Fanego, M. Wells, H. Hon, U. Kala, J. Lipman, R. C. Tasker, K. Kiff, I. Gordon, S. Campos, E. Quiňones, A. Davalos, X. Sevilla, Laurence Desplanques, Serge Gottot, Christian Dageville, A. Rodríguez-Núñez, M. de Hoog, R. C. Schoemaker, J. W. Mouton, J. N. van den Anker
Journal: Intensive Care Medicine (1996)
"MONGOLISM"
Authors: Gordon Allen, C.E. Benda, J.A. Böök, C.O. Carter, C.E. Ford, E.H.Y. Chu, E. Hanhart, George Jervis, W. Langdon-Down, J. Lejeune, Hideo Nishimura, J. Oster, L.S. Penrose, P.E. Polani, EdithL. Potter, Curt Stern, R. Turpin, J. Warkany, Herman Yannet
Journal: The Lancet (1961)
Piddosome-controlled liver ploidy is predictive for HCC outcome
Authors: Valentina Sladky, Katja Knapp, Kaoru Tsuchiya, Laura Bongiovanni, Bart Westendorp, Tamas Szabo, Gerald Timelthaler, Robert Eferl, Wolfgang Sieghart, Markus Peck-Radosavljevic, Merima Herac, Judith Stift, Georg Oberhuber, Tatjana Stojakovic, Hubert Schargl, Hilda van den Bos, Diana Spierings, Floris Foijer, Alain de Bruin, Matthias Pinter, Thomas Reiberger, Nataliya Rohr-Udilova, Andreas Villunger
Journal: Journal of Hepatology (2020)
Assessment of Testing for and Completeness of Reporting of Vancomycin-Resistant Enterococci—Connecticut, 1994
Journal: JAMA (1996)

From 1989 through 1993, the proportion of enterococcal isolates resistant to vancomycin (VRE) reported to CDC's National Nosocomial Infections Surveillance (NNIS) system increased from 0.3% to 7.9% (1). Since January 1994, clinical laboratories in Connecticut have been required to report all sterile-site VRE isolates to the Connecticut Department of Public Health (CDPH) to determine the epidemiology of VRE infection in the state. In 1995, CDPH surveyed all clinical laboratories in the state to identify microbiologic methods used to determine antimicrobial susceptibility of enterococcal isolates and to assess the completeness of reporting in 1994. This report summarizes the survey findings and the assessment of reporting for VRE, which confirmed for the first time that VRE infections were occurring statewide in Connecticut.
Die Nahbestrahlung
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Lectures on Bright's Disease.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
"This Phenomena"
Authors: William Dressler
Journal: JAMA (1965)

<h3>To the Editor:—</h3> Probably because of lack of training in the classical languages, we have allowed some odd expressions to invade our language. An example can be found in the Nov 16, 1964, issue ofThe Journal(<b>190</b>:589), where one reads: "This phenomena could be comparable...." Since the singular is phenomenon, and the plural, phenomena, obviously the sentence should read either "This phenomenon" or "These phenomena." A similar error often encountered is "this criteria."
Screening Surgeons for HIV Infection
Authors: Douglas K. Owens
Journal: Annals of Internal Medicine (1995)

Letters15 November 1995Screening Surgeons for HIV InfectionDouglas K. Owens, MD, MSc, Ryan A. Harris, MSc, and Robert F. Nease, PhDDouglas K. Owens, MD, MScVeterans Affairs Medical Center, Palo Alto, CA 94304; Washington University St. Louis, MO 63110Search for more papers by this author, Ryan A. Harris, MScVeterans Affairs Medical Center, Palo Alto, CA 94304; Washington University St. Louis, MO 63110Search for more papers by this author, and Robert F. Nease, PhDVeterans Affairs Medical Center, Palo Alto, CA 94304; Washington University St. Louis, MO 63110Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-123-10-199511150-00029 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Drs. Burke and Brown suggest that test costs may be lower than the estimates we used and that geographically targeted screening may be more cost-effective than screening all surgeons. We agree that some purchasers will be able to negotiate for relatively low-cost HIV tests. The military HIV screening program is particularly efficient [1]. Our estimate of $57, however, represents the total cost per patient screened and includes the cost of the enzyme immunoassay and any necessary confirmatory tests, counseling before and after the test, and administrative overhead. The cost of the tests alone is a minor component of ...References1. Brown AE, Burke DS. Cost of HIV testing in the U.S. Army. N Engl J Med. 1995; 332:963. Google Scholar2. Owens DK, Harris RA, Scott PM, Nease RF Jr. Screening surgeons for HIV infection. A cost-effectiveness analysis. Ann Intern Med. 1995; 122:641-52. Google Scholar Author, Article, and Disclosure InformationAuthors: Douglas K. Owens, MD, MSc; Ryan A. Harris, MSc; Robert F. Nease, PhDAffiliations: Veterans Affairs Medical Center, Palo Alto, CA 94304; Washington University St. Louis, MO 63110 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 November 1995Volume 123, Issue 10Page: 812-813KeywordsArmed forcesEnzyme immunoassayHIVHIV infectionsHealth careSurgeons ePublished: 15 August 2000 Issue Published: 15 November 1995 Copyright & PermissionsCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Medicine at a Glance
Journal: JAMA (1984)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE DIAGNOSTIC VALUE OF THE GRUBER-WIDAL REACTION.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Physician's assistant or assistant physician?
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
573P The incidence of post-transplant malignancies in kidney transplantation recipients in King Chulalongkorn Memorial Hospital: A single institute with 44 year’s experience in Thailand
Authors: S. Uttamapinan, P. Puapatanakul, T. Rattananupong, V. Sriuranpong, N. Townamchai, N. Parinyanitikul
Journal: Annals of Oncology (2016)
"Miss U."
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Administration of levodopa for relief of herpes zoster pain
Authors: S. Kernbaum
Journal: JAMA (1981)

Forty-seven outpatients with herpes zoster, seen within five days of onset of the eruption, received ten days' administration of oral levodopa and benserazide or placebo in a double-blind controlled study. Both the total patient group and the high-risk group, eg, those with either ophthalmic zoster or those older than 65 years, were analyzed. Both groups were comparable in terms of demographic and pathological criteria. Vomiting was the only side effect observed in both groups. A significant decrease in intensity of pain was seen in the group receiving levodopa from the third day, and complete cessation of both pain and sleep disturbances was more frequent in the treated group. These differences were especially clear in the high-risk patients. Two months later, postherpetic neuralgia was also less frequent in the group that received levodopa. (<i>JAMA</i>1981;246:132-134)
Clofibrate in coronary heart disease. Effect on morbidity and mortality
Authors: L. R. Krasno
Journal: JAMA (1972)

A series of 1,001 men free of coronary heart disease and 67 with disease with an average age of 47.5 years were divided in two groups pairmatched for risk factors. One group was treated with an antilipemic agent (clofibrate) whereas the other remained untreated for 39 months. The nonfatal myocardial infarction rate was 6.6/1,000/yr and 1.89/1,000/yr for untreated and treated men, respectively. Two younger unmatched treated and untreated groups totaling 2,218 men who had an average age of 37.5 years and were free of coronary heart disease were observed for 32.4 and 22.8 months, respectively. The incidence of nonfatal myocardial infarction was 5.0/1,000/yr in the untreated and 0.64/1,000/yr in the treated individuals. These results were observed notwithstanding the persistence of varying degrees of hyperlipidemia in some treated individuals. There was no significant difference in mortality at this time.
Influence of education and occupation on the incidence of Alzheimer's disease
Authors: Y. Stern
Journal: JAMA (1994)

Objective.\p=m-\Severalcross-sectional studies have found an association between Alzheimer's disease (AD) and limited educational experience.It has been difficult to establish whether educational experience is a risk factor for AD because edu- cational attainment can influence performance on diagnostic tests.This study was designed to determine whether limited educational level and occupational attain- ment are risk factors for incident dementia.Design.\p=m-\Cohort incidence study.Setting.\p=m-\Generalcommunity. Participants.\p=m-\Atotal of 593 nondemented individuals aged 60 years or older who were listed in a registry of individuals at risk for dementia in North Manhattan, NY, were identified and followed up.Interventions.\p=m-\Wereexamined subjects 1 to 4 years later with the identical standardized neurological and neuropsychological measures.Main Outcome Measure.\p=m-\Incidentdementia.Results.\p=m-\Weused Cox proportional hazards models, adjusting for age and gender, to estimate the relative risk (RR) of incident dementia associated with low educational and occupational attainment.Of the 593 subjects, 106 became demented; all but five of these met research criteria for AD.The risk of dementia was increased in subjects with either low education (RR, 2.02; 95% confidence in- terval [CI], 1.33 to 3.06) or low lifetime occupational attainment (RR, 2.25; 95% CI, 1.32 to 3.84).Risk was greatest for subjects with both low education and low l i f e\ x=r eq-\ time occupational attainment (RR, 2.87; 95% CI, 1.32 to 3.84).Conclusions.\p=m-\Thedatasuggest that increased educational and occupational attainment may reduce the risk of incident AD, either by decreasing ease of clinical detection of AD or by imparting a reserve that delays the onset of clinical manifes- tations.
Brucellosis
Authors: Georgios Pappas, Nikolaos Akritidis, Mile Bosilkovski, Epameinondas Tsianos
Journal: New England Journal of Medicine (2005)

Brucellosis has been present for millennia and has managed to elude eradication, even in most developed countries. Brucellosis causes much clinical morbidity as well as an important loss of agricultural productivity in the developing world. In this era of international tourism, brucellosis has become a common imported disease in the developed world. This review article discusses the pathogenesis and treatment of the disease.
Resistance to β-Adrenoceptor Stimulants
Journal: BMJ (1972)

The British Government has given £45,000 to the Intemational Agency for Research on Cancer (I.A.R.C.) in Lyons, France.The donation is to be used for a mass spectrometer which will measure cancer-producing substances in food and will be housed in a new I.A.R.C. building which is a gift from the French authorities.The new spectro- meter will play a part in the I.A.R.C. pro- gramme to identify the causes of cancer ex- isting in the human environment.